Quest Diagnostics Incorporated · NYSE:DGX

Delaney Mark E received 2,615 Quest Diagnostics Incorporated shares as an award (Form 4)

Traded Nov 3, 2026 · Filed Nov 5, 2026

On Nov 3, 2026, Delaney Mark E (SVP & Chief Commercial Officer) received 2,615 Quest Diagnostics Incorporated shares as an award, leaving 12,975 shares. Filed Nov 5, 2026 (Form 4).

Awarded
2,615 shares
Holding after
12,975 shares
Trading plan
No
Role
SVP & Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 3, 2026Common StockAward2,61512,975Direct

Source

Download original · View original at SEC

Related